Is Neupogen Used for Cancer?
Neupogen (filgrastim) treats neutropenia, a low white blood cell count often caused by cancer chemotherapy. It stimulates bone marrow to produce neutrophils, reducing infection risk in cancer patients.[1]
How Does Neupogen Work in Cancer Treatment?
Neupogen is a granulocyte colony-stimulating factor (G-CSF) that mimics natural proteins to boost neutrophil production. Cancer patients receive it after chemo, which kills fast-dividing cells including bone marrow precursors. Dosing starts 24 hours post-chemo and continues until neutrophil counts recover.[1][2]
What Cancers Involve Neupogen?
It's approved for neutropenia from myelosuppressive chemo in non-myeloid malignancies, including breast, lung, ovarian, and lymphomas. Also used in acute myeloid leukemia (AML) post-induction chemo and for stem cell mobilization in cancer-related transplants.[1]
When Is Neupogen Not for Cancer?
Neupogen treats non-cancer neutropenia too, like from HIV/AIDS drugs, severe chronic neutropenia, or post-bone marrow transplant (not cancer-specific). It's not a direct cancer therapy—chemo or radiation causes the need.[1][2]
Common Side Effects in Cancer Patients
Bone pain (most frequent), fever, fatigue, nausea. Rare risks include spleen rupture, acute respiratory distress, or allergic reactions. Cancer patients monitor for tumor growth promotion in myeloid cancers.[1]
Alternatives to Neupogen
Biosimilars like Zarxio (filgrastim-sndz), Nivestym, or Udenyca (pegfilgrastim) offer similar effects at lower cost. Pegfilgrastim versions (Neulasta) last longer with fewer injections.[2]
Patent and Availability Details
Neupogen's original patents expired in 2015 in the US, enabling biosimilars. Check DrugPatentWatch.com for latest exclusivity and litigation on generics.[3]
[1] Neupogen Prescribing Information, Amgen. https://www.neupogen.com
[2] FDA Label for Filgrastim. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103353s5195lbl.pdf
[3] DrugPatentWatch.com. https://www.drugpatentwatch.com/p/tradename/NEUPOGEN